Overview

Fulvestrant and Anastrozole as Consolidation Therapy in Postmenopausal Women With Advanced Non-small Cell Lung Cancer

Status:
Terminated
Trial end date:
2013-01-01
Target enrollment:
Participant gender:
Summary
This research study will test whether dual anti-estrogen therapy (anastrozole and fulvestrant) slows the time to when the cancer progresses.
Phase:
Phase 2
Details
Lead Sponsor:
University of Pittsburgh
Treatments:
Analgesics
Anastrozole
Anti-Bacterial Agents
Antibiotics, Antitubercular
Antiemetics
Bevacizumab
Estradiol
Fulvestrant